• AI Pickup
  • menu
  • U.S. Stock Market Prediction
    • U.S. Stock Forecast Tomorrow
    World Stock Markets
  • ETF Market Prediction
    • ETF Forecast Tomorrow
  • Cryptocurrency Prediction
  • Forex Market Prediction
  • Sign In Sign Up
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
Go to >>
Interactive chart
Long term forecast
Analyst ratings
Financial Info
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
Go to >>
Interactive chart
Long term forecast
Analyst ratings
Financial Info
Quick Access Forecast in this page:
Long term
Analysts
    You are here:
  • Home
  • USA stock market prediction
  • GILD forecast

Gilead Sciences Inc. (GILD) stock prediction

Will Gilead Sciences Inc. stock go up? Is Gilead Sciences Inc. stock a good buy now?

From AI system, total return is 1747.99% from 1300 forecasts. Forecast for Mar. 2021 is $66.27 , for Feb. 2022 is $127.45 , for Feb. 2024 is $160.54 , for Feb. 2026 is $172.84 , and for Feb. 2031 is $105.38.

Since closing price on 2021-02-24 is $63.71 and forecast for Feb. 2022 is $127.45, Gilead Sciences Inc. stock is a good 1 year investment. Please, see more forecasts below.

Table of contents

  • Interactive chart
  • Long term forecast
  • Analyst ratings by institutions
  • Financial Info
  • Frequently Asked Questions (FAQ)
  • 14 Days Historical Data

Statistics

Statistics from all past short term forecast signals in AI Pickup
Total return : 1747.99 %
Number of direction forecasts : 1300

Click to see the forecast history of all tickers

Chart for Gilead Sciences Inc. (GILD) stock

<GILD Chart by Tradingview>

Long term forecast for Gilead Sciences Inc. stock

GILD long term forecast chart
Date
Price
Mar. 2021
$66.2747724726856
Apr. 2021
$67.4054449738114
May. 2021
$71.233801814322
Jun. 2021
$79.3512688422823
Jul. 2021
$92.3349324800762
Aug. 2021
$105.775237967074
Sep. 2021
$114.295780509408
Oct. 2021
$118.663423490802
Nov. 2021
$121.234968779524
Dec. 2021
$123.745574659957
Jan. 2022
$125.656560560654
Feb. 2022
$127.449991623012
Mar. 2022
$128.669236621854
Apr. 2022
$129.492524203175
May. 2022
$130.163962592959
Jun. 2022
$130.578267701921
Jul. 2022
$130.72263757975
Aug. 2022
$129.853029248753
Sep. 2022
$127.946717919125
Oct. 2022
$124.657976564278
Nov. 2022
$120.190818339259
Dec. 2022
$116.874528887185
Jan. 2023
$117.464438507931
Feb. 2023
$121.635983233017
Mar. 2023
$127.214053272374
Apr. 2023
$132.802067399276
May. 2023
$137.424516999983
Jun. 2023
$141.433917853156
Jul. 2023
$145.451658566077
Aug. 2023
$148.829492995873
Sep. 2023
$151.808342160979
Oct. 2023
$153.933476536721
Nov. 2023
$155.844111844587
Dec. 2023
$157.43056564888
Jan. 2024
$158.948951324005
Feb. 2024
$160.54487113471
Mar. 2024
$161.984915248344
Apr. 2024
$163.096485752242
May. 2024
$164.211009735132
Jun. 2024
$165.194135774908
Date
Price
Jul. 2024
$166.142754980981
Aug. 2024
$167.091310442903
Sep. 2024
$168.210466500761
Oct. 2024
$169.08914774924
Nov. 2024
$169.840319447811
Dec. 2024
$170.425575745539
Jan. 2025
$170.85418079236
Feb. 2025
$171.142229986382
Mar. 2025
$171.218903575924
Apr. 2025
$171.237006914788
May. 2025
$171.174877615683
Jun. 2025
$171.257649395664
Jul. 2025
$171.519032286548
Aug. 2025
$171.904015086082
Sep. 2025
$172.323345358943
Oct. 2025
$172.681056285905
Nov. 2025
$172.983894122943
Dec. 2025
$173.090846184177
Jan. 2026
$173.017795387212
Feb. 2026
$172.83716571153
Mar. 2026
$172.553674224299
Apr. 2026
$172.135682578608
May. 2026
$171.580109807163
Jun. 2026
$170.888422025433
Jul. 2026
$170.001358421107
Aug. 2026
$168.94193063267
Sep. 2026
$167.658038440761
Oct. 2026
$166.186653452921
Nov. 2026
$164.642780741449
Dec. 2026
$163.012853426223
Jan. 2027
$161.352445782828
Feb. 2027
$159.756430355896
Mar. 2027
$158.426950472049
Apr. 2027
$157.37914536713
May. 2027
$156.646034511323
Jun. 2027
$156.191336858722
Jul. 2027
$155.975371675375
Aug. 2027
$155.846735978801
Sep. 2027
$155.725951436816
Oct. 2027
$155.868897695274
Date
Price
Nov. 2027
$156.529754556003
Dec. 2027
$157.679146589452
Jan. 2028
$158.963994943624
Feb. 2028
$160.04283282602
Mar. 2028
$160.950857631976
Apr. 2028
$161.76740958135
May. 2028
$162.387587049762
Jun. 2028
$162.795868336461
Jul. 2028
$162.975223129125
Aug. 2028
$162.935404282845
Sep. 2028
$162.747996479114
Oct. 2028
$162.476032059176
Nov. 2028
$162.181714690312
Dec. 2028
$161.92219100383
Jan. 2029
$161.730916054943
Feb. 2029
$161.613881793838
Mar. 2029
$161.418930932247
Apr. 2029
$161.264415110395
May. 2029
$161.185552971671
Jun. 2029
$161.201010928271
Jul. 2029
$161.158939788658
Aug. 2029
$160.986055027314
Sep. 2029
$160.577550636087
Oct. 2029
$159.899854695486
Nov. 2029
$159.079541841208
Dec. 2029
$158.174544882421
Jan. 2030
$157.216459669935
Feb. 2030
$156.172978543255
Mar. 2030
$154.968097226422
Apr. 2030
$153.644418060309
May. 2030
$152.211959500636
Jun. 2030
$150.556162684158
Jul. 2030
$148.447059962375
Aug. 2030
$145.851684985231
Sep. 2030
$142.648031447848
Oct. 2030
$139.153534597827
Nov. 2030
$132.705675619046
Dec. 2030
$123.559951692453
Jan. 2031
$113.612315723149
Feb. 2031
$105.37556214075

Analyst rating for Gilead Sciences Inc. stock

Date
Firm
Analysis
2021-02-11
SVB Leerink
Price target is $72.0000. Prior price target was $73.0000.
Analyst rating is Outperform.
2021-02-05
SVB Leerink
Price target is $73.0000. Prior price target was $74.0000.
Analyst rating is Outperform.
2021-02-05
Morgan Stanley
Price target is $87.0000. Prior price target was $83.0000.
Analyst rating is Overweight.
2021-02-05
Credit Suisse
Price target is $66.0000. Prior price target was $65.0000.
Analyst rating is Neutral.
2021-01-19
Morgan Stanley
Price target is $83.0000. Analyst rating is Overweight. Prior analyst rating was Equal-Weight
2020-10-29
BMO Capital
Price target is $64.0000. Prior price target was $74.0000.
Analyst rating is Market Perform.
2020-10-29
Cantor Fitzgerald
Price target is $86.0000. Prior price target was $84.0000.
Analyst rating is Overweight.
2020-10-29
Wells Fargo
Price target is $63.0000. Prior price target was $69.0000.
Analyst rating is Equal-Weight.
2020-10-29
Piper Sandler
Price target is $84.0000. Prior price target was $95.0000.
Analyst rating is Overweight.
2020-10-29
SVB Leerink
Price target is $79.0000. Prior price target was $88.0000.
Analyst rating is Outperform.
2020-10-28
UBS
Price target is $61.0000. Analyst rating is Neutral.
2020-09-18
RBC Capital
Price target is $86.0000. Prior price target was $82.0000.
Analyst rating is Outperform.
2020-09-15
RBC Capital
Price target is $82.0000. Prior price target was $84.0000.
Analyst rating is Outperform.
2020-09-15
Maxim Group
Price target is $88.0000. Analyst rating is Buy. Prior analyst rating was Hold
2020-09-14
SVB Leerink
Price target is $88.0000. Prior price target was $94.0000.
Analyst rating is Outperform.
2020-09-10
Oppenheimer
Price target is $105.0000. Prior price target was $90.0000.
Analyst rating is Outperform.
2020-08-20
Truist Securities
Price target is $67.0000. Prior price target was $74.0000.
Analyst rating is Hold.
2020-08-19
Piper Sandler
Price target is $83.0000. Prior price target was $85.0000.
Analyst rating is Overweight.
2020-08-19
Cantor Fitzgerald
Price target is $84.0000. Prior price target was $86.0000.
Analyst rating is Overweight.
2020-07-31
Credit Suisse
Price target is $73.0000. Prior price target was $75.0000.
Analyst rating is Neutral.
2020-07-31
Morgan Stanley
Price target is $79.0000. Prior price target was $80.0000.
Analyst rating is Equal-Weight.
2020-07-20
Credit Suisse
Price target is $75.0000. Prior price target was $64.0000.
Analyst rating is Neutral. Prior analyst rating was Underperform
2020-07-15
Morgan Stanley
Price target is $80.0000. Prior price target was $77.0000.
Analyst rating is Equal-Weight.
2020-05-26
SunTrust Robinson Humphrey
Price target is $73.0000. Prior price target was $70.0000.
Analyst rating is Hold. Prior analyst rating was Sell
2020-05-01
Morgan Stanley
Price target is $77.0000. Prior price target was $75.0000.
Analyst rating is Equal-Weight.
2020-05-01
JP Morgan
Analyst rating is Neutral. Prior analyst rating was Overweight
2020-05-01
SunTrust Robinson Humphrey
Analyst rating is Sell. Prior analyst rating was Hold
2020-05-01
Raymond James
Analyst rating is Market Perform. Prior analyst rating was Outperform
2020-05-01
SVB Leerink
Price target is $85.0000. Prior price target was $68.0000.
Analyst rating is Market Perform.
2020-05-01
Oppenheimer
Price target is $90.0000. Prior price target was $80.0000.
Analyst rating is Outperform.
2020-04-29
CFRA
Price target is $74.0000. Prior price target was $71.0000.
Analyst rating is Sell.
2020-04-27
UBS
Analyst rating is Neutral. Prior analyst rating was Buy
2020-04-20
Wells Fargo
Price target is $87.0000. Analyst rating is Equal-Weight. Prior analyst rating was Overweight
2020-04-20
BMO Capital
Price target is $79.0000. Analyst rating is Market Perform. Prior analyst rating was Outperform
2020-04-17
CFRA
Analyst rating is Sell. Prior analyst rating was Hold
2020-04-07
Cantor Fitzgerald
Price target is $86.0000. Prior price target was $78.0000.
Analyst rating is Overweight.
2020-03-20
Piper Sandler
Analyst rating is Overweight. Prior analyst rating was Neutral
2020-03-18
DZ Bank
Analyst rating is Buy. Prior analyst rating was Hold
2020-03-09
RBC Capital
Price target is $86.0000. Analyst rating is Outperform. Prior analyst rating was Top Pick
2020-02-28
DZ Bank
Analyst rating is Hold. Prior analyst rating was Buy
2020-02-27
Barclays
Price target is $62.0000. Analyst rating is Underweight.
2020-02-06
Bernstein
Price target is $70.0000. Prior price target was $78.0000.
Analyst rating is Market Perform. Prior analyst rating was Outperform
2020-02-05
Credit Suisse
Price target is $60.0000. Prior price target was $59.0000.
Analyst rating is Underperform.
2020-02-05
B of A Securities
Price target is $72.0000. Prior price target was $70.0000.
Analyst rating is Neutral.
2020-02-05
Raymond James
Price target is $80.0000. Prior price target was $81.0000.
Analyst rating is Outperform. Prior analyst rating was Strong Buy
2020-01-21
Guggenheim Securities
Analyst rating is Neutral. Prior analyst rating was Buy
2019-12-13
Credit Suisse
Price target is $63.0000. Prior price target was $67.0000.
Analyst rating is Underperform. Prior analyst rating was Neutral
2019-11-12
SunTrust Robinson Humphrey
Price target is $70.0000. Analyst rating is Hold.
2019-10-25
Oppenheimer
Price target is $80.0000. Prior price target was $85.0000.
Analyst rating is Outperform.
2019-10-25
Maxim Group
Analyst rating is Hold. Prior analyst rating was Buy
2019-10-25
BMO Capital
Price target is $81.0000. Prior price target was $82.0000.
Analyst rating is Outperform.
2019-10-25
Raymond James
Price target is $81.0000. Prior price target was $85.0000.
Analyst rating is Strong Buy.
2019-10-17
Bank of America
Price target is $70.0000. Analyst rating is Neutral.

Financial Data for Gilead Sciences Inc. stock

Market Cap
79862390784
Held Percent By Insiders
0.11%
Held Percent By Institutions
80.069%
Sector
Healthcare
Website
http://www.gilead.com
currency
USD

Dividend Rate
2.84
Dividend Yield
4.46%
Forward PE
9.396754
Trailing PE
650.10205
Enterprise Value
1.107337216E11
Enterprise To Ebitda
9.311
Enterprise To Revenue
4.485

Average 10 day Volume
7492700
Average Volume
9091773
Fifty Two Week High
$85.97
Fifty Two Week Low
$56.56

Frequently Asked Questions for Gilead Sciences Inc. stock

Is Gilead Sciences Inc. a good long term stock?

For 1 year investment, Gilead Sciences Inc. (GILD) stock can be a good investment choice. According to AI Pickup, the Gilead Sciences Inc. stock price forecast for Feb. 2022 is $127.449991623012
For 5 year investment, Gilead Sciences Inc. (GILD) stock can be a good investment choice. According to AI Pickup, the Gilead Sciences Inc. stock price forecast for Feb. 2026 is $172.83716571153
For 10 year investment, Gilead Sciences Inc. (GILD) stock can be a good investment choice. According to AI Pickup, the Gilead Sciences Inc. stock price forecast for Feb. 2031 is $105.37556214075

Is Gilead Sciences Inc. stock overvalued?

Gilead Sciences Inc. (GILD) stock is expected to go UP . Therefore, AI Pickup would say that Gilead Sciences Inc. (GILD) stock is NOT overvalued.

Will Gilead Sciences Inc. stock price go up?

Yes. The Gilead Sciences Inc. stock price forecast for Feb. 2022 is $127.449991623012

14 Days Historical Data for Gilead Sciences Inc. stock

Date
Close
Open
Low
High
2021-02-04
$65.83
$64.89
$64.44
$65.99
2021-02-05
$68.46
$67.25
$66.71
$69.36
2021-02-08
$67.97
$68.5
$67.31
$68.76
2021-02-09
$67.3
$67.77
$66.85
$67.84
2021-02-10
$67.29
$67.26
$67.1
$68.32
2021-02-11
$66.92
$67.2
$66.05
$67.2
2021-02-12
$66.89
$66.78
$66.36
$67.27
2021-02-16
$64.8
$66.41
$64.52
$66.6
2021-02-17
$65.1
$64.33
$63.84
$65.14
2021-02-18
$65.23
$64.86
$64.33
$65.46
2021-02-19
$64.37
$65.08
$64.27
$65.22
2021-02-22
$64.11
$63.93
$63.53
$64.47
2021-02-23
$63.68
$63.85
$62.78
$64.16
2021-02-24
$63.71
$63.56
$62.81
$64.23
    • About
    • Company
    • Contact
    • Terms of Use
    • Privacy Policy
    • COPYRIGHT © 2020 by AI Pickup. All rights reserved.